110 related articles for article (PubMed ID: 32493660)
21. Relative contribution of digital rectal examination and transrectal ultrasonography in interpreting serum prostate-specific antigen values for screening prostate cancer in Arab men.
Sheikh M; Sinan T; Kehinde EO; Hussein AY; Anim JT; Al-Hunayan AA
Ann Saudi Med; 2007; 27(2):73-8. PubMed ID: 17356323
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of prostate specific antigen density and transrectal ultrasonography-guided biopsies in 100 consecutive patients with a negative digital rectal examination and intermediate serum prostate specific antigen levels.
Tarcan T; Ozveri H; Biren T; Türkeri L; Akdas A
Int J Urol; 1997 Jul; 4(4):362-7. PubMed ID: 9256325
[TBL] [Abstract][Full Text] [Related]
23. [Evolution of the number of incident cases of prostate cancer in France from 2001 to 2012 from 5 hospital centers].
Helfrich O; Crouzet S; Ruffion A; Houlgatte A; Cavillon C; Gerard C; Villers A
Prog Urol; 2015 Mar; 25(3):147-56. PubMed ID: 25481672
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis of prostate cancer with needle biopsy: should all cases be biopsied before treatment?
Oranusi CK; Ugezu AI; Nwofor A
Niger J Clin Pract; 2012; 15(1):48-50. PubMed ID: 22437089
[TBL] [Abstract][Full Text] [Related]
25. A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam.
Roobol MJ; Zhu X; Schröder FH; van Leenders GJ; van Schaik RH; Bangma CH; Steyerberg EW
Eur Urol; 2013 Apr; 63(4):627-33. PubMed ID: 22841675
[TBL] [Abstract][Full Text] [Related]
26. Digital rectal examination and prostate-specific antigen abnormalities at the time of prostate biopsy and biopsy outcomes, 1980 to 1997.
Roberts RO; Bergstralh EJ; Lieber MM; Jacobsen SJ
Urology; 2000 Nov; 56(5):817-22. PubMed ID: 11068309
[TBL] [Abstract][Full Text] [Related]
27. Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy.
Campos-Fernandes JL; Bastien L; Nicolaiew N; Robert G; Terry S; Vacherot F; Salomon L; Allory Y; Vordos D; Hoznek A; Yiou R; Patard JJ; Abbou CC; de la Taille A
Eur Urol; 2009 Mar; 55(3):600-6. PubMed ID: 18597923
[TBL] [Abstract][Full Text] [Related]
28. Detection rates and biologic significance of prostate cancer with PSA less than 4.0 ng/mL: observation and clinical implications from Tyrol screening project.
Pelzer AE; Tewari A; Bektic J; Berger AP; Frauscher F; Bartsch G; Horninger W
Urology; 2005 Nov; 66(5):1029-33. PubMed ID: 16286118
[TBL] [Abstract][Full Text] [Related]
29. Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone.
Salido-Guadarrama AI; Morales-Montor JG; Rangel-Escareño C; Langley E; Peralta-Zaragoza O; Cruz Colin JL; Rodriguez-Dorantes M
Mol Med Rep; 2016 Jun; 13(6):4549-60. PubMed ID: 27081843
[TBL] [Abstract][Full Text] [Related]
30. Utility of digital rectal examination, serum prostate specific antigen, and transrectal ultrasound in the detection of prostate cancer: a developing country perspective.
Kash DP; Lal M; Hashmi AH; Mubarak M
Asian Pac J Cancer Prev; 2014; 15(7):3087-91. PubMed ID: 24815452
[TBL] [Abstract][Full Text] [Related]
31. Screening for prostate cancer at low PSA range: the impact of digital rectal examination on tumor incidence and tumor characteristics.
Gosselaar C; Roobol MJ; Roemeling S; van der Kwast TH; Schröder FH
Prostate; 2007 Feb; 67(2):154-61. PubMed ID: 17044079
[TBL] [Abstract][Full Text] [Related]
32. Prostate cancer in patients with an abnormal digital rectal examination and serum prostate-specific antigen less than 4.0 ng/mL.
Bozeman CB; Carver BS; Caldito G; Venable DD; Eastham JA
Urology; 2005 Oct; 66(4):803-7. PubMed ID: 16230142
[TBL] [Abstract][Full Text] [Related]
33. The value of endorectal MRI in the early diagnosis of prostate cancer.
Comet-Batlle J; Vilanova-Busquets JC; Saladié-Roig JM; Gelabert-Mas A; Barceló-Vidal C
Eur Urol; 2003 Aug; 44(2):201-7; discussion 207-8. PubMed ID: 12875939
[TBL] [Abstract][Full Text] [Related]
34. Characteristics of prostate cancer detected by digital rectal examination only.
Okotie OT; Roehl KA; Han M; Loeb S; Gashti SN; Catalona WJ
Urology; 2007 Dec; 70(6):1117-20. PubMed ID: 18158030
[TBL] [Abstract][Full Text] [Related]
35. Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States.
Kelly SP; Anderson WF; Rosenberg PS; Cook MB
Eur Urol Focus; 2018 Jan; 4(1):121-127. PubMed ID: 29162421
[TBL] [Abstract][Full Text] [Related]
36. Role of transperineal six-core prostate biopsy in patients with prostate-specific antigen level greater than 10 ng/mL and abnormal digital rectal examination findings.
Luciani LG; De Giorgi G; Valotto C; Zanin M; Bierti S; Zattoni F
Urology; 2006 Mar; 67(3):555-8. PubMed ID: 16527579
[TBL] [Abstract][Full Text] [Related]
37. Stratification of prostate-specific antigen level and results of transrectal ultrasonography and digital rectal examination as predictors of positive prostate biopsy.
Clark TW; Goldenberg L; Cooperberg PL; Wong AD; Singer J
Can Assoc Radiol J; 1997 Aug; 48(4):252-8. PubMed ID: 9282157
[TBL] [Abstract][Full Text] [Related]
38. Clinical Significance of Proliferative Inflammatory Atrophy in Negative Prostatic Biopsies.
Servian P; Celma A; Planas J; Placer J; de Torres IM; Morote J
Prostate; 2016 Dec; 76(16):1501-1506. PubMed ID: 27404228
[TBL] [Abstract][Full Text] [Related]
39. Impact of PSA and DRE on histologic findings at prostate biopsy in Turkish men over 75 years of age.
Verim L; Yildirim A; Basok EK; Peltekoglu E; Pelit ES; Zemheri E; Tokuc R
Asian Pac J Cancer Prev; 2013; 14(10):6085-8. PubMed ID: 24289630
[TBL] [Abstract][Full Text] [Related]
40. Is a digital rectal examination necessary in the diagnosis and clinical staging of early prostate cancer?
Philip J; Dutta Roy S; Ballal M; Foster CS; Javlé P
BJU Int; 2005 May; 95(7):969-71. PubMed ID: 15839915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]